Application no. and date | 05735686.7 (espacenet) (Federated) (European Patent Register), 20050414 | Patent/reg. no. and date | DK/EP 1745064, 20110105 | Publication date | 20070124 | Priority no. and date | US 562340 P, 20040415, US 569096 P, 20040507, US 599401 P, 20040806, US 610001 P, 20040914, US 610002 P, 20040914, US 610159 P, 20040914, US 620573 P, 20041020 | EP pub. no. and date |
EP 1745064 20070124 | Effective date | | Applicant/owner | Onyx Therapeutics, Inc., 249 East Grand Avenue
South San Francisco, CA 94080, US | Applicant ref. no. | P005846EPDK1 | Inventor | SMYTH, Mark S., 860 Pollux Court
Foster City, CA 94404, US, LAIDIG, Guy J., 329 Waverley Street
Menlo Park, CA 94025, US, BORCHARDT, Ronald T., 3100 Campfire Drive
Lawrence, KS 66049, US, BUNIN, Barry A., 4171 George Ave No. 4
San Mateo, CA 94403, US, CREWS, Craig M., 286 Livington Street
New Haven, CT 06511, US, MUSSER, John H., 23 Michael Court
San Carlos, CA 94070, US, CHABALA, John Clifford, 602 Sherwood Parkway
Mountainside, NJ 07092, US | Representative | CHAS. HUDE A/S, Langebrogade 3B, 1411 København K, DK | Opponent | | IPC Class | A61K 38/06 (2006.01) , C07K 5/08 (2006.01) , C07K 5/087 (2006.01) | Title | Forbindelser til proteasomenzyminhibering | Int. application no. | US2005012740 | Int. publication no. | WO2005105827 | Related patent (certificate) | | Status | Udløbet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|